Sanjeev Pathak

Summary

Affiliation: Cincinnati Children's Hospital Medical Center
Country: USA

Publications

  1. ncbi request reprint Comparative efficacy of cognitive behavioral therapy, fluoxetine, and their combination in depressed adolescents: initial lessons from the treatment for adolescents with depression study
    Sanjeev Pathak
    University of Cincinnati College of Medicine, Children s Hospital Medical Center, MLC D 3014, 3333 Burnet Avenue, Cincinnati, OH 45229, USA
    Curr Psychiatry Rep 7:429-34. 2005
  2. ncbi request reprint Psychotropic utilization and psychiatric presentation of hospitalized very young children
    Sanjeev Pathak
    Division of Child and Adolescent Psychiatry, Children s Hospital Medical Center, Cincinnati, OH 45229, USA
    J Child Adolesc Psychopharmacol 14:433-42. 2004
  3. ncbi request reprint Adjunctive quetiapine for treatment-resistant adolescent major depressive disorder: a case series
    Sanjeev Pathak
    Children s Hospital Medical Center, Division of Child and Adolescent Psychiatry, Cincinnati, Ohio 45229, USA
    J Child Adolesc Psychopharmacol 15:696-702. 2005
  4. ncbi request reprint Clinical characteristics of bipolar disorder in very young children
    Arman Danielyan
    Cincinnati Children s Hospital Medical Center, 3333 Burnet Avenue, D 3014, Cincinnati, OH 45229, United States
    J Affect Disord 97:51-9. 2007
  5. doi request reprint Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial
    Robert L Findling
    Division of Child and Adolescent Psychiatry, University Hospitals Case Medical Center, Cleveland, Ohio, USA
    J Child Adolesc Psychopharmacol 22:327-42. 2012
  6. pmc Drug-metabolizing enzyme genotypes and aggressive behavior treatment response in hospitalized pediatric psychiatric patients
    Cynthia A Prows
    Division of Patient Services, University of Cincinnati College of Medicine, Cincinnati, OH, USA
    J Child Adolesc Psychopharmacol 19:385-94. 2009
  7. ncbi request reprint The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review
    Drew H Barzman
    Bipolar and Psychotic Disorders Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267, USA
    J Child Adolesc Psychopharmacol 14:593-600. 2004
  8. ncbi request reprint Research knowledge among the participants in the Treatment for Adolescents With Depression Study (TADS)
    Benedetto Vitiello
    Division of Services and Intervention Research, National Institute of Mental Health, Bethesda, MD 20892 9633, USA
    J Am Acad Child Adolesc Psychiatry 46:1642-50. 2007
  9. ncbi request reprint SET-C versus fluoxetine in the treatment of childhood social phobia
    Deborah C Beidel
    Department of Psychology, University of Central Florida, Orlando, FL32186, USA
    J Am Acad Child Adolesc Psychiatry 46:1622-32. 2007
  10. pmc Treatment for Adolescents with Depression Study (TADS): safety results
    Graham Emslie
    UT Southwestern Medical Centre at Dallas, TX 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 45:1440-55. 2006

Detail Information

Publications17

  1. ncbi request reprint Comparative efficacy of cognitive behavioral therapy, fluoxetine, and their combination in depressed adolescents: initial lessons from the treatment for adolescents with depression study
    Sanjeev Pathak
    University of Cincinnati College of Medicine, Children s Hospital Medical Center, MLC D 3014, 3333 Burnet Avenue, Cincinnati, OH 45229, USA
    Curr Psychiatry Rep 7:429-34. 2005
    ..Moreover, the study results confirm that fluoxetine alone is effective in the treatment of depressed adolescents...
  2. ncbi request reprint Psychotropic utilization and psychiatric presentation of hospitalized very young children
    Sanjeev Pathak
    Division of Child and Adolescent Psychiatry, Children s Hospital Medical Center, Cincinnati, OH 45229, USA
    J Child Adolesc Psychopharmacol 14:433-42. 2004
  3. ncbi request reprint Adjunctive quetiapine for treatment-resistant adolescent major depressive disorder: a case series
    Sanjeev Pathak
    Children s Hospital Medical Center, Division of Child and Adolescent Psychiatry, Cincinnati, Ohio 45229, USA
    J Child Adolesc Psychopharmacol 15:696-702. 2005
    ..There is preliminary data in adults that adjunctive second-generation antipsychotics may be useful in treatment-resistant depression...
  4. ncbi request reprint Clinical characteristics of bipolar disorder in very young children
    Arman Danielyan
    Cincinnati Children s Hospital Medical Center, 3333 Burnet Avenue, D 3014, Cincinnati, OH 45229, United States
    J Affect Disord 97:51-9. 2007
    ..This study examined clinical presentations, applicability of the DSM-IV diagnostic criteria, comorbidity, recovery and relapse rates, as well as some treatment strategies used in the management of BPD in preschoolers...
  5. doi request reprint Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial
    Robert L Findling
    Division of Child and Adolescent Psychiatry, University Hospitals Case Medical Center, Cleveland, Ohio, USA
    J Child Adolesc Psychopharmacol 22:327-42. 2012
    ..The purpose of this study was to evaluate the efficacy and safety of acute quetiapine monotherapy in adolescents with schizophrenia...
  6. pmc Drug-metabolizing enzyme genotypes and aggressive behavior treatment response in hospitalized pediatric psychiatric patients
    Cynthia A Prows
    Division of Patient Services, University of Cincinnati College of Medicine, Cincinnati, OH, USA
    J Child Adolesc Psychopharmacol 19:385-94. 2009
    ..The aim of this study was to examine the association between the CYP2D6 and CYP2C19 genotype-predicted combined phenotypes and short-term measures of psychotropic efficacy and toxicity...
  7. ncbi request reprint The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review
    Drew H Barzman
    Bipolar and Psychotic Disorders Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267, USA
    J Child Adolesc Psychopharmacol 14:593-600. 2004
    ..The aim of this retrospective chart review was to evaluate the effectiveness and tolerability of aripiprazole for the treatment of children and adolescents with bipolar disorders...
  8. ncbi request reprint Research knowledge among the participants in the Treatment for Adolescents With Depression Study (TADS)
    Benedetto Vitiello
    Division of Services and Intervention Research, National Institute of Mental Health, Bethesda, MD 20892 9633, USA
    J Am Acad Child Adolesc Psychiatry 46:1642-50. 2007
    ..We examined the extent to which parents and adolescents participating in the Treatment for Adolescents With Depression Study (TADS) understood key aspects of the study...
  9. ncbi request reprint SET-C versus fluoxetine in the treatment of childhood social phobia
    Deborah C Beidel
    Department of Psychology, University of Central Florida, Orlando, FL32186, USA
    J Am Acad Child Adolesc Psychiatry 46:1622-32. 2007
    ..To determine the efficacy of fluoxetine, pill placebo, and Social Effectiveness Therapy for Children (SET-C) for children and adolescents with social phobia...
  10. pmc Treatment for Adolescents with Depression Study (TADS): safety results
    Graham Emslie
    UT Southwestern Medical Centre at Dallas, TX 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 45:1440-55. 2006
    ..To compare the rates of physical, psychiatric, and suicide-related events in adolescents with MDD treated with fluoxetine alone (FLX), cognitive-behavioral therapy (CBT), combination treatment (COMB), or placebo (PBO)...
  11. ncbi request reprint Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS)
    John Curry
    Duke Child and Family Study Center, NC 27705, USA
    J Am Acad Child Adolesc Psychiatry 45:1427-39. 2006
    ....
  12. ncbi request reprint Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS)
    Benedetto Vitiello
    J Am Acad Child Adolesc Psychiatry 45:1419-26. 2006
    ..To test whether 12-week treatment of major depression improved the level of functioning, global health, and quality of life of adolescents...
  13. ncbi request reprint Acute time to response in the Treatment for Adolescents with Depression Study (TADS)
    Christopher Kratochvil
    University of Nebraska Medical Center NE 68198 5581, USA
    J Am Acad Child Adolesc Psychiatry 45:1412-8. 2006
    ..To examine the time to response for both pharmacotherapy and psychotherapy in the Treatment for Adolescents with Depression Study (TADS)...
  14. ncbi request reprint Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS)
    Betsy Kennard
    UT Southwestern Medical Center, Dallas, TX 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 45:1404-11. 2006
    ....
  15. ncbi request reprint A manual-based intervention to address clinical crises and retain patients in the Treatment of Adolescents With Depression Study (TADS)
    Diane E May
    University of Nebraska Medical Center, Omaha, NE 68198 5581, USA
    J Am Acad Child Adolesc Psychiatry 46:573-81. 2007
    ..To describe a manual-based intervention to address clinical crises and retain participants in the Treatment for Adolescents With Depression Study (TADS)...
  16. ncbi request reprint Successful treatment of trichotillomania with olanzapine augmentation in an adolescent
    Sanjeev Pathak
    J Child Adolesc Psychopharmacol 14:153-4. 2004
  17. ncbi request reprint The use of sumatriptan in the treatment of obsessive-compulsive disorder in an adolescent
    Sanjeev Pathak
    J Child Adolesc Psychopharmacol 13:S93-4. 2003